[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-364068-105":59,"doc-detail-364068-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","fstl4-interaction-with-gi-proteins-activates-the-akt-mtor-pathway-to-drive-malignant-phenotypes-in-non-small-cell-lung-cancer","FSTL4 interaction with Gαi proteins activates the Akt-mTOR pathway to drive malignant phenotypes in non-small cell lung cancer","","Non-small cell lung cancer (NSCLC) presents a major clinical challenge, creating an urgent need for novel drivers and reliable prognostic biomarkers. The study examines Follistatin-like 4 (FSTL4) in NSCLC for clinical relevance, cellular localization, and mechanism. TCGA and patient tissues show elevated FSTL4 in tumors and reduced overall survival. Single-cell RNA sequencing localizes FSTL4 to malignant epithelial cells, and functional inhibition suppresses proliferation, migration, induces G1 arrest and intrinsic apoptosis via the Gαi1/3-Akt-mTOR axis.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/fstl4-interaction-with-gi-proteins-activates-the-akt-mtor-pathway-to-drive-malignant-phenotypes-in-non-small-cell-lung-cancer/364068/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/fstl4-interaction-with-gi-proteins-activates-the-akt-mtor-pathway-to-drive-malignant-phenotypes-in-non-small-cell-lung-cancer/364068.png","ImageObject",300,407,{"name":92,"@type":93},"LangkahRina","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-08","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",13,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"How is FSTL4 associated with NSCLC prognosis?","Question",{"text":113,"@type":114},"FSTL4 expression is significantly elevated in NSCLC tissues compared with normal lung tissues, and it serves as an independent prognostic indicator for reduced overall survival.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"Which cells show FSTL4 expression in lung adenocarcinoma?",{"text":118,"@type":114},"Single-cell RNA sequencing indicates that FSTL4 is predominantly and consistently localized to the malignant epithelial cell population across primary tumors and metastatic niches in LUAD.",{"name":120,"@type":111,"acceptedAnswer":121},"What mechanism links FSTL4 to malignant phenotypes?",{"text":122,"@type":114},"FSTL4 promotes malignancy by regulating the Akt-mTOR signaling cascade, physically interacting with inhibitory G-protein subunits Gɑi1 and Gɑi3, and activating Akt-mTOR; effects are rescued by constitutively active Akt1.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},364068,1790197342,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":19,"preview_urls":147},962090893776,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","Li etal. Cell Communication and Signaling (2026) 24:458  \n[https://doi.org/10.1186/s12964-026-03001-z](https://doi.org/10.1186/s12964-026-03001-z)  \nCell Communication and Signaling  \nRESEARCH Open Access  \nFSTL4 interaction with Gαi proteins activates the Akt-mTOR pathway to drive malignant phenotypes in non-small cell lung cancer  \nJiaxin Li1†, Wanghong Qi2,3†, Shansong Gao2,3†, Yifei Zhu4* and Jianhua Zha2,3*  \nAbstract  \nNon-small cell lung cancer (NSCLC) presents a critical challenge clinically; thus, identifying novel drivers and reliable prognostic biomarkers is imperative. Here, we investigated the clinical relevance, cell-type-specific localization, and mechanistic role of Follistatin-like 4 (FSTL4) in NSCLC. Analysis of The Cancer Genome Atlas (TCGA) and local resected tissue samples show that FSTL4 expression is significantly elevated in NSCLC tissues compared to normal lung tissues, and serves as an independent prognostic indicator for reduced overall survival. Single-cell RNA sequencing confirmed that FSTL4 expression is predominantly and consistently localized to the malignant epithelial cell population across primary tumors and metastatic niches in lung adenocarcinoma (LUAD) . Functionally,  \nstable knockdown or CRISPR/Cas9-mediated knockout of FSTL4 across multiple NSCLC cell types suppressed key malignant phenotypes, including cell proliferation, and migration, and inducing G1-phase cell cycle arrest and triggering intrinsic apoptosis. This cytotoxic dependency was selective to malignant cells, as normal lung epithelial cells remained unaffected. Conversely, ectopic overexpression of FSTL4 enhanced these aggressive characteristics. Mechanistically, FSTL4 exerts its pro-oncogenic effects through regulating the Akt-mTOR signaling cascade. FSTL4 physically interacts with the inhibitory G-protein subunits Gɑi1 and Gɑi3, and the co-depletion of these subunits inhibited FSTL4-mediated Akt-mTOR activation. Crucially, the functional effects of FSTL4 silencing in primary human NSCLC cells were rescued by the introduction of a constitutively active Akt1 (caAkt1, S473D) construct, confirming Akt as the essential required downstream transducer. In vivo validation further demonstrated that FSTL4 silencing profoundly attenuated NSCLC xenograft tumor growth by reducing proliferation and accelerating apoptosis, mirroring the diminished Akt-mTOR activation observed in vitro. Collectively, these comprehensive findings unequivocally establish that elevated FSTL4 expression promotes malignant phenotypes of NSCLC possibly by activating Gɑi1/3-Akt-mTOR cascade.  \n†Jiaxin Li, Wanghong Qi and Shansong Gao contributed equally to this work.  \n*Correspondence:  \nYifei Zhu [zhuyifei1119_rjh@163.com](zhuyifei1119_rjh@163.com)[ ](zhuyifei1119_rjh@163.com)Jianhua Zha [zhajianhua@ncu.edu.cn](zhajianhua@ncu.edu.cn)  \n1Department of Pharmacy, Jiangxi University of Chinese Medicine, Nanchang, China  \n2Department of Thoracic Surgery, The First Affiliated Hospital of Nanchang University, Nanchang, China  \n3China-Japan Friendship Jiangxi Hospital, National Regional Center for Respiratory Medicine, Nanchang, China  \n4Department of General Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If materi","cbCaieZJiNIqygRX","https://ap.wps.com/l/cbCaieZJiNIqygRX","pdf",13396615,18,"English","# Abstract\n# Introduction\n## Background and clinical challenges in NSCLC\n## Targeted therapy context and rationale","[{\"question\":\"How is FSTL4 associated with NSCLC prognosis?\",\"answer\":\"FSTL4 expression is significantly elevated in NSCLC tissues compared with normal lung tissues, and it serves as an independent prognostic indicator for reduced overall survival.\"},{\"question\":\"Which cells show FSTL4 expression in lung adenocarcinoma?\",\"answer\":\"Single-cell RNA sequencing indicates that FSTL4 is predominantly and consistently localized to the malignant epithelial cell population across primary tumors and metastatic niches in LUAD.\"},{\"question\":\"What mechanism links FSTL4 to malignant phenotypes?\",\"answer\":\"FSTL4 promotes malignancy by regulating the Akt-mTOR signaling cascade, physically interacting with inhibitory G-protein subunits Gɑi1 and Gɑi3, and activating Akt-mTOR; effects are rescued by constitutively active Akt1.\"}]","FSTL4 interaction with Gαi proteins activates the Akt-mTOR pathway to drive malignant phenotypes in non-small cell lung cancer | PDF",1790155519,45,[148,152,156,160],{"page_no":8,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8de0d7fc8a119611011461cea0017dd0.webp",983,1310,{"page_no":14,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/bf83f9e154ccf2c9f2bd64cdbaacf4a7.webp",982,1309,{"page_no":81,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/361cb127c3949d542d8ac15393c45eb4.webp",981,1308,{"page_no":19,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1d87254bd3c736461f91c79eb67f2a12.webp",980,1306]